Evidence map›Paper›PMID 41429890›Full record

ArticleScientific reports2025

A novel sub-differentiable hausdorff loss combined with BCE for MRI brain tumor segmentation using UNet variants.

Gurugubelli Visalakshi, Laavanya Mohan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gurugubelli VisalakshiVignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India. visalisowji@gmail.com.
Laavanya MohanVignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumor segmentation is a crucial yet complex task in medical image analysis, playing a vital role in accurate diagnosis and treatment planning. However, it faces several inherent challenges: (1) class imbalance, where tumors occupy a minimal portion of MRI scans, leading models to favor healthy tissue; (2) low sensitivity to small or irregular tumors, resulting in high false negatives; and (3) limitations of standard loss functions, which often fail to properly emphasize tumor boundaries.TraditionalHausdorff Loss, despite its effectiveness in boundary alignment, suffers from non-differentiability and high sensitivity to outliers, leading to unstable optimization and poor boundary predictions. To address these challenges, we propose a novel Sub-Differentiable Hausdorff Loss (SDHL), which introduces a smooth, differentiable formulation enabling stable gradient-based learning and robust boundary alignment. Furthermore, to balance fine boundary precision with accurate tumor region segmentation, we introduce a novel SDHL combined with BCE loss. This combination leverages SDHL's boundary sensitivity and BCE's region accuracy, resulting in sharper tumor boundaries and more complete segmentation outcomes. This study presents a deep learning-based brain tumor segmentation pipeline utilizing various UNet-derived architectures including UNet, UNet+, VNet, UNet++, and Attention UNet, all trained using the proposed loss functions. The models evaluated using performance metrics such as Accuracy, Precision, Recall, Dice Score, and Intersection over Union (IoU). Among the tested configurations, Semantic segmentationmetricsofAttention UNet with SDHL + BCE outperformed all others, achieving 99.71% accuracy, 91.06% precision, 91.85% recall, 90.16% Dice score, and 80.78% IoU. The integration of the proposed loss functions significantly improves segmentation quality, addressing key challenges and offering a robust solution for brain tumor segmentation in medical imaging.Additionally, the Attention UNet model demonstrated strong consistency across evaluation metrics, achieving 97.92% accuracy, 98.76% precision, 98.05% recall, 98.57% F1-score, and a Matthews correlation coefficient of 93.41%, indicating robust and reliable performance.

Indexed as

Brain NeoplasmsImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedMagnetic Resonance ImagingAlgorithmsHumansBoundary alignmentGradient-based optimizationLoss function designMedical image analysisSub-differentiable hausdorff loss (SDHL)Tumor segmentation

Identifiers

PMID41429890
PMCPMC12749605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.